← Back to Search

Optical Lens

Spectacle Lenses for Nearsightedness (BIRCH Trial)

N/A
Waitlist Available
Research Sponsored by SightGlass Vision, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

BIRCH Trial Summary

This trial looks at how eye sight changes after wearing certain glasses.

Who is the study for?
This trial is for individuals who previously participated in the CYPRESS Extension study, have near-sightedness, and are willing to wear special glasses daily for up to a year. They must not use contact lenses during this period and need consent from parents or guardians if underage.Check my eligibility
What is being tested?
The study tests what happens to near-sightedness (both eye prescription changes and eye length growth) after people stop using certain spectacle lenses they were wearing before.See study design
What are the potential side effects?
Since this trial involves only wearing glasses, there aren't typical medication side effects. However, participants might experience discomfort adjusting to not wearing the specialized lenses anymore.

BIRCH Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Axial Length (AL)
Cycloplegic Spherical Equivalent Refraction (cSER)

BIRCH Trial Design

2Treatment groups
Active Control
Group I: Control Lens GroupActive Control1 Intervention
Group II: Test Lens GroupActive Control1 Intervention

Find a Location

Who is running the clinical trial?

SightGlass Vision, Inc.Lead Sponsor
10 Previous Clinical Trials
1,003 Total Patients Enrolled

Media Library

Spectacle Lenses (Optical Lens) Clinical Trial Eligibility Overview. Trial Name: NCT05893979 — N/A
Myopia or Nearsightedness Research Study Groups: Control Lens Group, Test Lens Group
Myopia or Nearsightedness Clinical Trial 2023: Spectacle Lenses Highlights & Side Effects. Trial Name: NCT05893979 — N/A
Spectacle Lenses (Optical Lens) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05893979 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do I qualify to become a participant in this clinical examination?

"This particular trial is taking in approximately 90 individuals who suffer from near-sightedness and are aged between 9 to 16."

Answered by AI

What is the geographic distribution of this research endeavor?

"Currently, the trial is occuring at 9 distinct medical centres. These are located in Longwood, Pittsburg, Raytown and other locations. Participants should select a nearby site to reduce transportation demands if they decide to join this study."

Answered by AI

Could potential participants still join this research endeavor?

"Per the information provided on clinicaltrials.gov, this research endeavour has stopped recruiting candidates as of May 30th 2023 and was first posted June 30th 2023. Although not currently accepting patients for this trial, 114 other studies are actively seeking participants at this time."

Answered by AI

Is geriatric enrollment accepted in this research protocol?

"As indicated by the trial's guidelines, anyone between 9 and 16 years old may be eligible to enrol."

Answered by AI

Who else is applying?

What site did they apply to?
Golden Optometric Group
What portion of applicants met pre-screening criteria?
Did not meet criteria
~40 spots leftby Dec 2024